SGRL Q4 FY26 Guidance vs Delivery (SGRL Management Mirror)

Did SGRL's management deliver what it guided? Guidance vs actual performance and tone changes across recent earnings calls, as of the Q4 FY26 (Mar-2026 Qtr) concall.

  • SGRL Financials
  • SGRL Shareholding Pattern
  • SGRL Earnings Documents
  • SGRL Announcements
  • SGRL Corporate Actions
  • SGRL Bulk, Block & Insider Deals
  • SGRL Delivery Data
  • SGRL Earnings Concalls
  • Market Timeline
  • Concall Monitor
  • Company Research
  • Earnings Monitor
  • Upcoming Results
  • Sector Monitor
  • Sector Performance
  • Bulk & Block Deals
  • Delivery Data
  • FII & DII Activity
  • Market Indices
  • Plans & Pricing

Shree Ganesh Remedies Ltd (SGRL) Q4FY26 Management Mirror - Mar-2026 Qtr

Financial & Margin Outlook

Management expects FY27 business momentum to gradually improve, reaffirming long-term sustainable EBITDA margins of 26% to 28% in the Mar'26 Qtr, remaining consistent with the Sep'25 Qtr upgrade from the initially guided 24% to 26% range set in the Mar'25 Qtr. [Status: Reaffirmed]

3 more themes on the ELITE plan.

  • SGRL Q4FY26 Concall Summary
  • SGRL Q4FY26 Concall Transcript
  • SGRL Q2FY26 Management Mirror (Sep-2025 Qtr)